What is TuHURA Biosciences, Inc.'s interest paid?

TuHURA Biosciences, Inc. (HURA) reported interest paid of $27.92K in Q1 2026.

What does interest paid mean?

Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.

TuHURA Biosciences, Inc. HURA Interest Paid

Interest Paid at other companies

CTO

Citius Oncology, Inc.CTOR

$14.46K-69.1%

Inhibrx Biosciences, Inc.INBX

$2.78M+114%

ImmunityBio, Inc.IBRX

$20.12M+29.0%

Vera TherapeuticsVERA

$1.63M+3.2%

Other financials

Income statement

See full

Revenue-—

Net income-$7.5M-13.1%

EPS (diluted)-$0.13+13.3%

Balance sheet

See full

Cash & equivalents$6.3M+1.3%

Total debt$456.9K+178%

Total equity$23.2M+135%

Total assets$29.7M+103%

Cash flow

See full

Operating cash flow-$4.4M+6.9%

CapEx$48.8K+14.5%

Free cash flow-$4.5M+6.7%

Valuation

See full

Market cap$155.39M+45.8%

Enterprise value$149.54M+52.3%

Returns & leverage

See full

Return on equity-187.2%—

Debt / equity0×0.0×

Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s interest paid?: TuHURA Biosciences, Inc. (HURA) reported interest paid of $27.92K in Q1 2026.
What does interest paid mean?: Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.